MELANOMA BRAF V600E/K MUTATED
Clinical trials for MELANOMA BRAF V600E/K MUTATED explained in plain language.
Never miss a new study
Get alerted when new MELANOMA BRAF V600E/K MUTATED trials appear
Sign up with your email to follow new studies for MELANOMA BRAF V600E/K MUTATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Melanoma study on zapping resistant tumors with surgery or radiation pulled before start
Disease control TerminatedThis study planned to test whether adding surgery, radiation, or electrochemotherapy could help control melanoma spots that didn't shrink with the targeted drug combo encorafenib + binimetinib. It was designed for adults with BRAF-mutated melanoma who had been on the drugs for at…
Matched conditions: MELANOMA BRAF V600E/K MUTATED
Phase: PHASE4 • Sponsor: SRH Wald-Klinikum Gera GmbH • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New combo therapy hopes to boost immune attack on Hard-to-Treat melanoma
Disease control OngoingThis study tests a new drug called BI-1607 combined with two existing immunotherapies (ipilimumab and pembrolizumab) for people with advanced melanoma that has spread or cannot be removed. The goal is to see if adding BI-1607 helps the immune system better destroy cancer cells. A…
Matched conditions: MELANOMA BRAF V600E/K MUTATED
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 26, 2026 12:00 UTC